Oxycare Antibiotic Tablets for Dogs
Oxycare Tablets for Dogs are an oral antibiotic medication used to treat a wide range of bacterial infections in dogs. These tablets contain the active ingredient oxytetracycline, which belongs to a group of antibiotics known as tetracyclines. Oxytetracycline is effective against a broad spectrum of bacteria and is commonly prescribed by veterinary surgeons to manage infections that are sensitive to tetracycline therapy.
A Veterinary Pet Prescription is required for Oxycare
Oxycare works by inhibiting the growth and spread of bacteria. It does this by interfering with the bacteria’s ability to produce proteins that are essential for their survival and multiplication. This prevents the bacteria from replicating and allows y...
Oxycare Antibiotic Tablets for Dogs
Oxycare Tablets for Dogs are an oral antibiotic medication used to treat a wide range of bacterial infections in dogs. These tablets contain the active ingredient oxytetracycline, which belongs to a group of antibiotics known as tetracyclines. Oxytetracycline is effective against a broad spectrum of bacteria and is commonly prescribed by veterinary surgeons to manage infections that are sensitive to tetracycline therapy.
A Veterinary Pet Prescription is required for Oxycare
Oxycare works by inhibiting the growth and spread of bacteria. It does this by interfering with the bacteria’s ability to produce proteins that are essential for their survival and multiplication. This prevents the bacteria from replicating and allows your dog’s immune system to fight off the remaining infection.
Vets often choose oxytetracycline when treating infections caused by bacteria that are known to respond to tetracycline-based antibiotics. This includes conditions affecting the respiratory tract, urinary system, skin, and soft tissues.
How Oxycare Works
Oxytetracycline, the active ingredient in Oxycare Tablets, is a broad-spectrum antibiotic. It works by binding to the bacterial ribosome and blocking the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. This action prevents the synthesis of proteins that the bacteria need to survive. Without these proteins, the bacteria cannot grow, multiply, or sustain themselves.
Unlike bactericidal antibiotics, which kill bacteria directly, oxytetracycline is bacteriostatic. This means it halts the growth and replication of bacteria, allowing the dog’s natural immune defences to eliminate the infection.
Oxytetracycline is particularly effective against a range of Gram-positive and Gram-negative bacteria. It also has efficacy against certain intracellular organisms, which makes it useful in treating infections where bacteria reside inside host cells.
Conditions Treated with Oxycare
Oxycare Tablets are used to manage bacterial infections that are proven or strongly suspected to be sensitive to tetracycline therapy. These conditions include:
-
Respiratory tract infections: These are often caused by bacteria such as Bordetella bronchiseptica, Pasteurella multocida, and Streptococcus spp. Dogs suffering from kennel cough, bronchitis, or pneumonia may benefit from treatment with oxytetracycline.
-
Urinary tract infections (UTIs): Oxytetracycline is sometimes used in the treatment of UTIs caused by susceptible organisms such as Escherichia coli and Proteus spp.
-
Skin and wound infections: Cuts, abrasions, bite wounds, and skin infections can become contaminated with bacteria. Oxytetracycline helps control the spread of infection and promotes healing.
-
Soft tissue infections: These include infections of the mouth, gums, and surrounding tissues. Conditions such as gingivitis and certain oral infections may respond well to Oxycare treatment.
-
Tick-borne diseases: Some tick-borne diseases like ehrlichiosis are caused by intracellular bacteria sensitive to tetracyclines. Oxytetracycline is often part of the treatment plan for such infections.
-
Other bacterial infections: Oxytetracycline may be used in other conditions where laboratory testing or clinical experience suggests susceptibility to tetracycline therapy.
